Kontafarma China Holdings Limited (HKG:1312)

Kontafarma China Holdings Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	66.06	80.59	77.66	122.6	167.96
Short-Term Investments	-	10	10	20	16
Cash & Short-Term Investments	66.06	90.59	87.66	142.6	183.96
Cash Growth	-27.07%	3.34%	-38.53%	-22.49%	-5.56%
Accounts Receivable	137.88	108.71	106.52	255.11	273.38
Other Receivables	52.86	241.46	258.59	117.3	116.53
Receivables	190.74	350.17	365.11	379.04	401.72
Inventory	90.92	85.96	98.27	111.74	129.19
Prepaid Expenses	5.91	4.77	2.16	3.04	5.82
Other Current Assets	18.38	25.53	34.57	53.09	59.99
Total Current Assets	372.01	557.01	587.76	689.5	780.68
Property, Plant & Equipment	411.1	486.7	574.41	801.17	1,110
Goodwill	141.9	253.3	253.42	301.26	358.78
Other Intangible Assets	92.88	222.55	249.36	262.32	271.57
Long-Term Deferred Tax Assets	0.12	0.26	0.16	0.16	0.23
Long-Term Deferred Charges	1.52	1.74	2.17	6.48	7.13
Other Long-Term Assets	45.66	65.88	60.06	59.56	30.45
Total Assets	1,065	1,587	1,727	2,120	2,559

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.95	6.66	6.67	21.4	39.27
Accrued Expenses	127.88	80.69	66.67	81.41	67.97
Current Portion of Long-Term Debt	65.52	88.05	39.55	158.77	226.71
Current Portion of Leases	63.24	62.45	66.13	63.81	79.88
Current Income Taxes Payable	51.6	39.41	36.32	29.68	28.09
Current Unearned Revenue	114.64	120.89	127.81	72.69	93.24
Other Current Liabilities	31.98	44.16	40.44	76.96	167.42
Total Current Liabilities	462.8	442.31	383.6	504.71	702.57
Long-Term Debt	10.96	-	12.8	103.15	17.1
Long-Term Leases	63.96	146.68	215.34	264.99	405.27
Long-Term Unearned Revenue	0.64	0.75	0.98	22.83	14.55
Long-Term Deferred Tax Liabilities	39.39	25.8	40.43	55.14	67.26
Other Long-Term Liabilities	11.17	10.36	12.23	13.34	14.25
Total Liabilities	588.92	625.9	665.39	964.16	1,221

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	11.18	11.18	11.18	11.18	11.18
Additional Paid-In Capital	1,524	1,524	1,524	1,524	1,524
Retained Earnings	-566.3	-138.88	-63.34	-34.5	7.05
Comprehensive Income & Other	-415.56	-417.55	-414.49	-399.52	-350.15
Total Common Equity	553.27	978.7	1,057	1,101	1,192
Minority Interest	-77.01	-17.17	4.66	55.17	145.77
Shareholders' Equity	476.26	961.54	1,062	1,156	1,338
Total Liabilities & Equity	1,065	1,587	1,727	2,120	2,559

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	203.68	297.19	333.82	590.72	728.95
Net Cash (Debt)	-137.62	-206.6	-246.16	-448.13	-544.99
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.02	-0.04	-0.04	-0.08	-0.10
Filing Date Shares Outstanding	5,589	5,589	5,589	5,589	5,589
Total Common Shares Outstanding	5,589	5,589	5,589	5,589	5,589
Working Capital	-90.79	114.7	204.16	184.8	78.12
Book Value Per Share	0.10	0.18	0.19	0.20	0.21
Tangible Book Value	318.49	502.85	554.51	537.53	561.67
Tangible Book Value Per Share	0.06	0.09	0.10	0.10	0.10
Buildings	189.08	130.08	132.7	151.62	205.88
Machinery	116.14	104.42	93.33	102.84	182.41
Construction In Progress	13.03	56.61	55.92	171.95	161.71
Leasehold Improvements	78.13	78.4	79.51	77.8	138.33

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error